John G. Ullman & Associates’s Solventum SOLV Stock Holding History

John G. Ullman & Associates’s Portfolio SOLV Stock Details SOLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.97M	Buy	25,488 +140	+0.6%	+$10.2K	0.24%	86
2026 Q1	$1.66M	Sell	25,348 -1,900	-7%	-$141K	0.22%	85
2025 Q4	$2.16M	Sell	27,248 -650	-2%	-$49.8K	0.29%	83
2025 Q3	$2.04M	Sell	27,898 -602	-2%	-$44.1K	0.27%	83
2025 Q2	$2.16M	Sell	28,500 -500	-2%	-$35.4K	0.32%	79
2025 Q1	$2.21M	Sell	29,000 -450	-2%	-$33.5K	0.34%	85
2024 Q4	$1.95M	Sell	29,450 -450	-2%	-$31.5K	0.29%	88
2024 Q3	$2.08M	Sell	29,900 -42,350	-59%	-$2.55M	0.3%	86
2024 Q2	$3.82M	Buy	+72,250	New	+$4.39M	0.58%	53

Other funds holding SOLV

IFP

Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TFM

Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

John G. Ullman & Associates's SOLV Position: Q2 2026 in Review

John G. Ullman & Associates increased its Solventum (SOLV) stake by 0.55% in Q2 2026, buying an estimated $10.2K and bringing the position to 25,488 shares worth $1.97M. The position accounts for 0.24% of the portfolio, ranked #86.

John G. Ullman & Associates first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.82M in Q2 2024. 873 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

John G. Ullman & Associates held 25,488 shares of Solventum worth $1.97M as of Q2 2026.
John G. Ullman & Associates bought 140 Solventum shares in Q2 2026, an estimated $10.2K.
Solventum made up 0.24% of John G. Ullman & Associates's portfolio in Q2 2026, its #86 holding.
John G. Ullman & Associates first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
John G. Ullman & Associates's Solventum position peaked at $3.82M in Q2 2024.
873 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on John G. Ullman & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.